Literature DB >> 10160474

Hidden costs of antibiotics.

E T Smyth, J G Barr, G M Hogg.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 10160474     DOI： 10.2165/00019053-199610010-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  Technique for calculation of the true costs of antibiotic therapy.

Authors:  J R Kerr; J G Barr; E T Smyth; J O'Hare
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  Unnecessary and ecological cost of hospital infection.

Authors:  F Daschner
Journal:  J Hosp Infect       Date:  1991-06       Impact factor: 3.926

Review 3.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

4.  An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins.

Authors:  E T Smyth; J G Barr; C A O'Neill; G M Hogg
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

5.  Human and non-financial costs of hospital-acquired infection.

Authors:  P Davey; C Hernanz; W Lynch; M Malek; D Byrne
Journal:  J Hosp Infect       Date:  1991-06       Impact factor: 3.926

6.  What is the cost of nephrotoxicity associated with aminoglycosides?

Authors:  J M Eisenberg; H Koffer; H A Glick; M L Connell; L E Loss; G H Talbot; N H Shusterman; B L Strom
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391
  6 in total
  2 in total

Review 1.  Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Meropenem. A pharmacoeconomic review of its use in serious infections.

Authors:  S M Holliday; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.